Lyophilised vials
A familiar presentation for peptide research, with labelled content in milligrams. The material’s batch specification should define identity, analytical profile and storage requirements.
Form follows specificationThe next conversation
The next conversation
in peptide presentation.
Vials remain a familiar starting point. Pen, cartridge and nasal-spray formats bring additional questions about formulation, container design and product performance.
Aurelis presentation concepts. Exact device, formulation and availability are confirmed by enquiry.
Pen & cartridge platforms
A device and formulation must work as a complete system. Enquiries can cover material compatibility, container integrity, storage stability and device-performance documentation.
Dual-chamber cartridges
Two chambers can keep a lyophilised material and its diluent separated within a purpose-designed container. Established products use this architecture, but each new peptide formulation requires its own supporting data.
Semax & Selank nasal sprays
Intranasal routes have been studied for Semax and Selank. Ask for the finished formulation’s concentration, fill volume, pump delivery, spray characteristics and storage specification.
Start with a complete brief
Four details to confirm.
Compound
Identity and the required amount of each component.
Formulation
Total content, fill volume and relevant excipients.
Container
The vial, pump, cartridge or device specification.
Performance
Applicable analytical, stability and delivery data.
Format research & technical references
These sources explain product-development considerations. They do not certify Aurelis concepts or establish that one format is suitable for every peptide.
Connect with Aurelis
Your next enquiry
starts with the details.
Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.